17 companies

Ascendis Pharma

Market Cap: US$14.0b

Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally.

ASND

US$227.41

7D

-0.04%

1Y

37.0%

Madrigal Pharmaceuticals

Market Cap: US$10.2b

A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.

New

MDGL

US$442.00

7D

2.4%

1Y

29.7%

Insmed

Market Cap: US$31.0b

Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.

INSM

US$142.70

7D

2.4%

1Y

80.8%

Alnylam Pharmaceuticals

Market Cap: US$42.5b

Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally.

ALNY

US$314.80

7D

-1.8%

1Y

24.2%

BridgeBio Pharma

Market Cap: US$13.8b

A biopharmaceutical company, discovers, develops, and delivers medicines for patients with genetic diseases.

BBIO

US$70.12

7D

-1.8%

1Y

107.8%

BeOne Medicines

Market Cap: US$31.9b

An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.

ONC

US$282.29

7D

-5.6%

1Y

6.0%

Ionis Pharmaceuticals

Market Cap: US$11.9b

A commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.

IONS

US$71.67

7D

-4.2%

1Y

115.0%

AbbVie

Market Cap: US$388.6b

A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.

ABBV

US$208.34

7D

-8.5%

1Y

-1.8%

Jazz Pharmaceuticals

Market Cap: US$11.2b

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.

JAZZ

US$180.45

7D

-2.7%

1Y

27.0%

Eli Lilly

Market Cap: US$831.1b

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.

LLY

US$918.05

7D

-8.2%

1Y

9.7%

BioMarin Pharmaceutical

Market Cap: US$10.8b

A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

BMRN

US$55.43

7D

-8.1%

1Y

-22.3%

Natera

Market Cap: US$28.1b

A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.

NTRA

US$197.79

7D

0.6%

1Y

31.1%

Royalty Pharma

Market Cap: US$26.6b

Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.

RPRX

US$45.79

7D

-1.9%

1Y

37.1%

Viatris

Market Cap: US$15.9b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

VTRS

US$13.74

7D

-1.6%

1Y

45.9%

Exact Sciences

Market Cap: US$19.8b

Provides cancer screening and diagnostic test products in the United States and internationally.

EXAS

US$103.75

7D

0.3%

1Y

127.0%

Elanco Animal Health

Market Cap: US$12.5b

An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.

ELAN

US$24.83

7D

5.9%

1Y

129.3%

Waters

Market Cap: US$29.1b

Provides analytical workflow solutions in Asia, the Americas, and Europe.

WAT

US$295.05

7D

-0.8%

1Y

-20.5%